136 related articles for article (PubMed ID: 33647797)
1. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
[TBL] [Abstract][Full Text] [Related]
2. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.
Dai H; Zhang P; Zhao S; Zhang J; Wang B
Oncol Rep; 2009 Feb; 21(2):395-401. PubMed ID: 19148513
[TBL] [Abstract][Full Text] [Related]
4. Ligand-dependent transcription of estrogen receptor alpha is mediated by the ubiquitin ligase EFP.
Nakajima A; Maruyama S; Bohgaki M; Miyajima N; Tsukiyama T; Sakuragi N; Hatakeyama S
Biochem Biophys Res Commun; 2007 May; 357(1):245-51. PubMed ID: 17418098
[TBL] [Abstract][Full Text] [Related]
5. Efp/TRIM25 and Its Related Protein, TRIM47, in Hormone-Dependent Cancers.
Azuma K; Inoue S
Cells; 2022 Aug; 11(15):. PubMed ID: 35954308
[TBL] [Abstract][Full Text] [Related]
6. Efp as a primary estrogen-responsive gene in human breast cancer.
Ikeda K; Orimo A; Higashi Y; Muramatsu M; Inoue S
FEBS Lett; 2000 Apr; 472(1):9-13. PubMed ID: 10781795
[TBL] [Abstract][Full Text] [Related]
7. Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
Nakayama H; Sano T; Motegi A; Oyama T; Nakajima T
Pathol Int; 2005 Nov; 55(11):707-15. PubMed ID: 16271083
[TBL] [Abstract][Full Text] [Related]
8. Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue.
Dai H; Zhao S; Xu L; Chen A; Dai S
Oncol Rep; 2010 Mar; 23(3):795-9. PubMed ID: 20127022
[TBL] [Abstract][Full Text] [Related]
9. Efp promotes growth of triple-negative breast cancer cells.
Sato W; Ikeda K; Gotoh N; Inoue S; Horie K
Biochem Biophys Res Commun; 2022 Oct; 624():81-88. PubMed ID: 35940131
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.
Zhao KW; Sikriwal D; Dong X; Guo P; Sun X; Dong JT
Biochem J; 2011 Jul; 437(2):323-33. PubMed ID: 21542805
[TBL] [Abstract][Full Text] [Related]
11. Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer.
Sakuma M; Akahira J; Suzuki T; Inoue S; Ito K; Moriya T; Sasano H; Okamura K; Yaegashi N
Gynecol Oncol; 2005 Dec; 99(3):664-70. PubMed ID: 16140366
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
Ueyama K; Ikeda K; Sato W; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
Cancer Gene Ther; 2010 Sep; 17(9):624-32. PubMed ID: 20467453
[TBL] [Abstract][Full Text] [Related]
13. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
14. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
[TBL] [Abstract][Full Text] [Related]
15. Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
Clin Breast Cancer; 2021 Oct; 21(5):399-407.e2. PubMed ID: 33386231
[TBL] [Abstract][Full Text] [Related]
16. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
[TBL] [Abstract][Full Text] [Related]
17. Promoter analysis of mouse estrogen-responsive finger protein (efp) gene: mouse efp promoter contains an E-box that is also conserved in human.
Ikeda K; Inoue S; Orimo A; Tsutsumi K; Muramatsu M
Gene; 1998 Aug; 216(1):155-62. PubMed ID: 9714786
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs.
Orimo A; Inoue S; Ikeda K; Noji S; Muramatsu M
J Biol Chem; 1995 Oct; 270(41):24406-13. PubMed ID: 7592654
[TBL] [Abstract][Full Text] [Related]
19. Systemic distribution of estrogen-responsive finger protein (Efp) in human tissues.
Shimada N; Suzuki T; Inoue S; Kato K; Imatani A; Sekine H; Ohara S; Shimosegawa T; Sasano H
Mol Cell Endocrinol; 2004 Apr; 218(1-2):147-53. PubMed ID: 15130519
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP.
Dong XY; Fu X; Fan S; Guo P; Su D; Dong JT
Biochem J; 2012 Jun; 444(3):581-90. PubMed ID: 22452784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
